Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies.

By sequencing cDNA clones which cover the complete coding region of human tenascin (TN), we have established its primary structure. This confirms that, as in the case of chicken, TN is mainly made up of three groups of sequences with a high homology to Epidermal Growth Factor (EGF) fibronectin (FN) type III repeat and fibrinogen. Furthermore, we have determined the amino-terminal sequence of the mature peptide directly on purified TN. The main differences with respect to the chicken TN molecule are that in the human there are 14 and half EGF-like repeats compared to 13 and half in the chicken and that, as previously reported, there are 15 FN-like repeats compared to 11 in the chicken. By Polymerase Chain Reaction (PCR) amplification we have also studied the different splicing patterns of the TN pre-mRNA in cultured cells. The results show the presence of at least four different isoforms containing different numbers of FN-like type III repeats. Using purified human TN as immunogen, we have obtained numerous monoclonal antibodies (Mabs) to TN. By screening a human melanoma cDNA library in the expression vector lambda gt11 with these Mabs and subsequently sequencing the insert of the positive clones, we have been able to localize, within the TN molecule, the epitopes recognized by two of these Mabs: BC-4, which recognizes an epitope within the EGF-like sequence and BC-2 which recognizes an epitope within the FN like type III repeats whose expression is regulated by alternative splicing of the TN pre-mRNA. Thus, while the Mab BC-4 may be useful in studies on TN distribution (since it recognizes all different TN isoforms) BC-2 may be useful in the study of the expression of particular TN isoforms generated by the alternative splicing of the TN primary transcript.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  M. Mottolese,et al.  Expression and production of tenascin in benign and malignant lesions of melanocyte lineage , 1990, International journal of cancer.

[3]  L. Old,et al.  Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Edelman,et al.  Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization , 1990, The Journal of cell biology.

[5]  G. Siegal,et al.  Tenascin expression in the human endometrium and in endometrial adenocarcinomas. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[6]  J. Gulcher,et al.  Chromosomal localization of the human hexabrachion (tenascin) gene and evidence for recent reduplication within the gene. , 1990, Genomics.

[7]  R. Chiquet‐Ehrismann What distinguishes tenascin from fibronectin? , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  G. Stamp Tenascin distribution in basal cell carcinomas , 1989, The Journal of pathology.

[9]  J. Spring,et al.  Two contrary functions of tenascin: Dissection of the active sites by recombinant tenascin fragments , 1989, Cell.

[10]  R. Chiquet‐Ehrismann,et al.  Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. , 1989, Cancer research.

[11]  L. Zardi,et al.  A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors , 1989, The Journal of cell biology.

[12]  J. Gulcher,et al.  An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Edelman,et al.  A detailed structural model of cytotactin: protein homologies, alternative RNA splicing, and binding regions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Ekblom,et al.  Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions [published erratum appears in J Cell Biol 1989 Mar;108(3):following 1175] , 1988, The Journal of cell biology.

[15]  M. Kusakabe,et al.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. , 1988, Developmental biology.

[16]  Y. Kawarada,et al.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Chiquet‐Ehrismann,et al.  Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme , 1987, The Journal of cell biology.

[18]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[19]  G. Heijne A new method for predicting signal sequence cleavage sites. , 1986 .

[20]  G. Edelman,et al.  Site-restricted expression of cytotactin during development of the chicken embryo , 1986, The Journal of cell biology.

[21]  J. Gulcher,et al.  Two large glycosylated polypeptides found in myelinating oligodendrocytes but not in myelin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Edelman,et al.  Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Timpl,et al.  The J1 glycoprotein—a novel nervous system cell adhesion molecule of the L2/HNK-1 family , 1985, Nature.

[24]  H. Erickson,et al.  A six-armed oligomer isolated from cell surface fibronectin preparations , 1984, Nature.

[25]  M. Chiquet,et al.  Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits , 1984, The Journal of cell biology.

[26]  D. Bigner,et al.  Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. , 1983, Cancer research.

[27]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[28]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[30]  C. Anfinsen,et al.  CHROMATOGRAPHY OF PEPSIN AND CHYMOTRYPSIN DIGESTS OF EGG WHITE LYSOZYME ON PHOSPHOCELLULOSE. , 1963, The Journal of biological chemistry.

[31]  B. Gusterson,et al.  The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia , 1990, Virchows Archiv. B, Cell pathology including molecular pathology.

[32]  L. Zardi,et al.  Tenascin: A hexameric adhesive glycoprotein , 1989, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[33]  M. Chiquet Tenascin/J1/cytotactin: the potential function of hexabrachion proteins in neural development. , 1989, Developmental neuroscience.

[34]  H. Erickson,et al.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. , 1989, Annual review of cell biology.

[35]  G. Kreil Transfer of proteins across membranes. , 1981, Annual review of biochemistry.